SOADOR
SUPN icon

State of Alaska Department of Revenue’s Supernus Pharmaceuticals SUPN Stock Holding History

State of Alaska Department of Revenue’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.51M Sell
32,585
-9,185
-22% -$441K 0.02% 831
2026
Q1 		$2.16M Sell
41,770
-880
-2% -$44.8K 0.02% 672
2025
Q4 		$2.12M Buy
42,650
+11,490
+37% +$559K 0.02% 670
2025
Q3 		$1.49M Sell
31,160
-2,154
-6% -$86.7K 0.02% 867
2025
Q2 		$1.05M Buy
33,314
+2,717
+9% +$87.1K 0.01% 1024
2025
Q1 		$1M Sell
30,597
-786
-3% -$27.9K 0.01% 1012
2024
Q4 		$1.13M Sell
31,383
-73
-0.2% -$2.57K 0.01% 991
2024
Q3 		$980K Sell
31,456
-857
-3% -$26.7K 0.01% 1078
2024
Q2 		$864K Sell
32,313
-969
-3% -$28.1K 0.01% 1083
2024
Q1 		$1.14M Sell
33,282
-329
-1% -$9.79K 0.01% 967
2023
Q4 		$972K Sell
33,611
-380
-1% -$10.1K 0.01% 1017
2023
Q3 		$937K Sell
33,991
-1,853
-5% -$56.4K 0.01% 987
2023
Q2 		$1.08M Sell
35,844
-1,174
-3% -$41.1K 0.01% 935
2023
Q1 		$1.34M Sell
37,018
-624
-2% -$24K 0.02% 834
2022
Q4 		$1.34M Buy
37,642
+572
+2% +$19.9K 0.02% 811
2022
Q3 		$1.25M Sell
37,070
-3,331
-8% -$108K 0.02% 809
2022
Q2 		$1.17M Buy
40,401
+3,405
+9% +$97.5K 0.01% 873
2022
Q1 		$1.2M Sell
36,996
-660
-2% -$20.2K 0.01% 910
2021
Q4 		$1.1M Sell
37,656
-1,115
-3% -$33.8K 0.01% 1032
2021
Q3 		$1.03M Buy
38,771
+2,077
+6% +$55.7K 0.01% 1066
2021
Q2 		$1.13M Buy
36,694
+870
+2% +$26.7K 0.01% 1007
2021
Q1 		$937K Sell
35,824
-5,180
-13% -$145K 0.01% 1090
2020
Q4 		$1.03M Sell
41,004
-8,268
-17% -$178K 0.01% 948
2020
Q3 		$1.03M Sell
49,272
-290
-0.6% -$6.58K 0.01% 871
2020
Q2 		$1.18M Buy
49,562
+3,010
+6% +$66.5K 0.02% 785
2020
Q1 		$837K Buy
46,552
+6,935
+18% +$146K 0.01% 846
2019
Q4 		$939K Sell
39,617
-675
-2% -$16.4K 0.01% 946
2019
Q3 		$1.11M Buy
40,292
+22,461
+126% +$666K 0.02% 807
2019
Q2 		$590K Buy
17,831
+195
+1% +$6.68K 0.01% 976
2019
Q1 		$617K Buy
17,636
+130
+0.7% +$4.84K 0.01% 945
2018
Q4 		$581K Buy
17,506
+447
+3% +$19.2K 0.01% 897
2018
Q3 		$858K Buy
17,059
+120
+0.7% +$5.93K 0.01% 806
2018
Q2 		$1.01M Buy
16,939
+300
+2% +$15.5K 0.02% 701
2018
Q1 		$762K Buy
16,639
+6,430
+63% +$268K 0.02% 755
2017
Q4 		$406K Buy
10,209
+240
+2% +$9.48K 0.01% 882
2017
Q3 		$398K Buy
9,969
+40
+0.4% +$1.73K 0.02% 761
2017
Q2 		$427K Buy
9,929
+4,399
+80% +$157K 0.03% 490
2017
Q1 		$173K Buy
5,530
+170
+3% +$4.56K 0.01% 734
2016
Q4 		$135K Buy
+5,360
New +$120K 0.01% 554

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

State of Alaska Department of Revenue's SUPN Position: Q2 2026 in Review

State of Alaska Department of Revenue reduced its Supernus Pharmaceuticals (SUPN) stake by 22% in Q2 2026, selling an estimated $441K and leaving 32,585 shares worth $1.51M. The position accounts for 0.02% of the portfolio, ranked #831.

State of Alaska Department of Revenue first reported a position in SUPN in Q4 2016 and has held it in 39 quarters since. The position peaked at $2.16M in Q1 2026. 197 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • State of Alaska Department of Revenue held 32,585 shares of Supernus Pharmaceuticals worth $1.51M as of Q2 2026.
  • State of Alaska Department of Revenue sold 9,185 Supernus Pharmaceuticals shares in Q2 2026, an estimated $441K.
  • Supernus Pharmaceuticals made up 0.02% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #831 holding.
  • State of Alaska Department of Revenue first reported a position in Supernus Pharmaceuticals in Q4 2016 and has held it in 39 quarters since.
  • State of Alaska Department of Revenue's Supernus Pharmaceuticals position peaked at $2.16M in Q1 2026.
  • 197 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.